IBBvsTMEDETF Comparison
VS
iShares Biotechnology ETF (IBB) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. IBB's top 3 sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. In contrast, TMED's top sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. Both IBB and TMED have the same Total Expense Ratio (TER) of 0.44%. IBB is up 20.17% year-to-date (YTD) with +$332M in YTD flows. TMED performs worse with 15.73% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of IBB and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IBB vs TMED performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IBB TMED | +1.32%-2.89% | +22.15%+7.47% | +20.17%+15.73% | +44.46%+32.67% | +60.12%n/a | +18.70%n/a |
| Flows | IBB TMED | +$288M+$4M | +$826M+$10M | +$332M+$13M | +$1.80B+$15M | -$589M- | -$1.26B- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IBB TMED | +24.50%+18.12% | +21.85%+18.46% | +21.07%n/a | +22.48%n/a |
| Max drawdown | IBB TMED | -6.57%-6.37% | -9.61%-11.09% | -24.82%n/a | -38.96%n/a |
| Max drawdown duration | IBB TMED | 22d21d | 151d125d | 377dn/a | 1523dn/a |
Trading data
IBB | TMED | |
Last sale 9/11/2026 at 1:30 PM | $202.93 | $33.80 |
| Previous close 09/10/2026 | $202.64 | $33.89 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
TMED
is actively managed and doesn’t replicate an indexIBB | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
IBB | TMED | |
|---|---|---|
| Last price | $202.93 | $33.80 |
| 1D performance | +0.14% | -0.25% |
| AuM | $10.30 B | $32.63 M |
| E/R | 0.44% | 0.44% |
Characteristics
IBB | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | T. Rowe Price |
| Benchmark | ICE Biotechnology Index | - |
| N° of holdings | 240 | 97 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 5, 2001 | June 11, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
IBB
USA
86.04%
Other
13.96%
TMED
USA
93.59%
Other
6.41%
Sectors
IBB
Healthcare
99.83%
Other
0.17%
TMED
Healthcare
98.58%
Other
1.42%
Diversification
IBB
Total weight of top 15 holdings out of 15
54.48%
TMED
Total weight of top 15 holdings out of 15
61.11%
Top 15 holdings
Data as of July 31, 2026
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
TMED
Eli Lilly & Co.
16.65%
UnitedHealth Group, Inc.
5.89%
Thermo Fisher Scientific, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.11%
Gilead Sciences, Inc.
3.76%
Danaher Corp.
3.58%
Cencora, Inc.
3.30%
Insulet Corp.
2.73%
Agilent Technologies, Inc.
2.69%
DexCom, Inc.
2.66%
Dyne Therapeutics, Inc.
2.60%
Stryker Corp.
2.49%
West Pharmaceutical Services, Inc.
2.29%
Waters Corp.
2.20%
McKesson Corp.
1.72%
Frequently asked questions about IBB and TMED
How have the IBB and TMED ETFs performed in 2026?
As of September 10, 2026, IBB is up 20.17% year-to-date (YTD), while TMED has returned 15.73%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: IBB or TMED?
Year-to-date, the IBB ETF saw +$332M in flows, compared to +$13M for TMED.
Which ETF is more volatile: IBB or TMED?
Over the past year, IBB had a volatility of 21.85%, while TMED experienced 18.46%.
Which ETF is bigger: IBB or TMED?
As of September 10, 2026, IBB holds $10.30 B in assets under management (AUM), while TMED manages $32.63 M.
What sectors do the IBB and TMED ETFs invest in?
IBB leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.
What are the top holdings of the IBB ETF and TMED ETF?
IBB top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc.. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..
Which ETF is more diversified: IBB or TMED?
IBB holds 241 securities with 54.48% of its assets in the top 15. TMED has 97 securities and a top 15 weight of 61.11%.
Advertisement
Latest news about IBB & TMED
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
IBB
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
IBB
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
IBB
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IBB
Advertisement
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Advertisement
